215 related articles for article (PubMed ID: 22731255)
1. Development of coronary heart disease and ischemic stroke in relation to fasting and 2-hour plasma glucose levels in the normal range.
Ning F; Zhang L; Dekker JM; Onat A; Stehouwer CD; Yudkin JS; Laatikainen T; Tuomilehto J; Pyörälä K; Qiao Q;
Cardiovasc Diabetol; 2012 Jun; 11():76. PubMed ID: 22731255
[TBL] [Abstract][Full Text] [Related]
2. Hyperglycemia and incidence of ischemic and hemorrhagic stroke-comparison between fasting and 2-hour glucose criteria.
Hyvärinen M; Tuomilehto J; Mähönen M; Stehouwer CD; Pyörälä K; Zethelius B; Qiao Q;
Stroke; 2009 May; 40(5):1633-7. PubMed ID: 19286584
[TBL] [Abstract][Full Text] [Related]
3. Fasting hyperinsulinaemia and 2-h glycaemia predict coronary heart disease in patients with type 2 diabetes.
Faghihi-Kashani S; Bonnet F; Hafezi-Nejad N; Heidari B; Aghajani Nargesi A; Sheikhbahaei S; Ebadi M; Esteghamati A
Diabetes Metab; 2016 Feb; 42(1):55-61. PubMed ID: 26531321
[TBL] [Abstract][Full Text] [Related]
4. The difference between 2-hour post-challenge and fasting plasma glucose associates with the risk of cardiovascular disease in a normoglycemic population: the Tehran lipid and glucose study.
Abdi A; Kohansal K; Khalili D; Azizi F; Hadaegh F
Nutr Metab (Lond); 2024 Feb; 21(1):10. PubMed ID: 38389086
[TBL] [Abstract][Full Text] [Related]
5. Impact of glucose tolerance status on development of ischemic stroke and coronary heart disease in a general Japanese population: the Hisayama study.
Doi Y; Ninomiya T; Hata J; Fukuhara M; Yonemoto K; Iwase M; Iida M; Kiyohara Y
Stroke; 2010 Feb; 41(2):203-9. PubMed ID: 19940278
[TBL] [Abstract][Full Text] [Related]
6. Association between HOMA-IR, fasting insulin and fasting glucose with coronary heart disease mortality in nondiabetic men: a 20-year observational study.
Kurl S; Zaccardi F; Onaemo VN; Jae SY; Kauhanen J; Ronkainen K; Laukkanen JA
Acta Diabetol; 2015 Feb; 52(1):183-6. PubMed ID: 24974303
[TBL] [Abstract][Full Text] [Related]
7. Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases?
DECODE Study Group, European Diabetes Epidemiology Group
Diabetes Care; 2003 Mar; 26(3):688-96. PubMed ID: 12610023
[TBL] [Abstract][Full Text] [Related]
8. Trajectories of Long-Term Normal Fasting Plasma Glucose and Risk of Coronary Heart Disease: A Prospective Cohort Study.
Yuan Z; Yang Y; Wang C; Liu J; Sun X; Liu Y; Li S; Xue F
J Am Heart Assoc; 2018 Feb; 7(4):. PubMed ID: 29440033
[TBL] [Abstract][Full Text] [Related]
9. The relation of fasting and 2-h postchallenge plasma glucose concentrations to mortality: data from the Baltimore Longitudinal Study of Aging with a critical review of the literature.
Sorkin JD; Muller DC; Fleg JL; Andres R
Diabetes Care; 2005 Nov; 28(11):2626-32. PubMed ID: 16249530
[TBL] [Abstract][Full Text] [Related]
10. Hyperglycemia and stroke mortality: comparison between fasting and 2-h glucose criteria.
Hyvärinen M; Qiao Q; Tuomilehto J; Laatikainen T; Heine RJ; Stehouwer CD; Alberti KG; Pyörälä K; Zethelius B; Stegmayr B;
Diabetes Care; 2009 Feb; 32(2):348-54. PubMed ID: 19017775
[TBL] [Abstract][Full Text] [Related]
11. Body surface area and glucose tolerance - The smaller the person, the greater the 2-hour plasma glucose.
Palmu S; Rehunen S; Kautiainen H; Eriksson JG; Korhonen PE
Diabetes Res Clin Pract; 2019 Nov; 157():107877. PubMed ID: 31622641
[TBL] [Abstract][Full Text] [Related]
12. Signs of dysregulated fibrinolysis precede the development of type 2 diabetes mellitus in a population-based study.
Hernestål-Boman J; Norberg M; Jansson JH; Eliasson M; Eriksson JW; Lindahl B; Johansson L
Cardiovasc Diabetol; 2012 Dec; 11():152. PubMed ID: 23249721
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular disease mortality in Europeans in relation to fasting and 2-h plasma glucose levels within a normoglycemic range.
Ning F; Tuomilehto J; Pyörälä K; Onat A; Söderberg S; Qiao Q;
Diabetes Care; 2010 Oct; 33(10):2211-6. PubMed ID: 20424221
[TBL] [Abstract][Full Text] [Related]
14. Effect of time of day and fasting duration on measures of glycaemia: analysis from the Whitehall II Study.
Hulmán A; Færch K; Vistisen D; Karsai J; Nyári TA; Tabák AG; Brunner EJ; Kivimäki M; Witte DR
Diabetologia; 2013 Feb; 56(2):294-7. PubMed ID: 23143165
[TBL] [Abstract][Full Text] [Related]
15. Demographic and cardiovascular risk factors modify association of fasting insulin with incident coronary heart disease and ischemic stroke (from the Atherosclerosis Risk In Communities Study).
Rasmussen-Torvik LJ; Yatsuya H; Selvin E; Alonso A; Folsom AR
Am J Cardiol; 2010 May; 105(10):1420-5. PubMed ID: 20451688
[TBL] [Abstract][Full Text] [Related]
16. Screening for diabetes mellitus--a two-step approach in individuals with impaired fasting glucose improves detection of those at risk of complications.
Tai ES; Lim SC; Tan BY; Chew SK; Heng D; Tan CE
Diabet Med; 2000 Nov; 17(11):771-5. PubMed ID: 11131101
[TBL] [Abstract][Full Text] [Related]
17. The association of early post-transplant glucose levels with long-term mortality.
Valderhaug TG; Hjelmesæth J; Hartmann A; Røislien J; Bergrem HA; Leivestad T; Line PD; Jenssen T
Diabetologia; 2011 Jun; 54(6):1341-9. PubMed ID: 21409415
[TBL] [Abstract][Full Text] [Related]
18. The impact of dyslipidaemia on cardiovascular mortality in individuals without a prior history of diabetes in the DECODE Study.
Zhang L; Qiao Q; Tuomilehto J; Hammar N; Ruotolo G; Stehouwer CD; Heine RJ; Eliasson M; Zethelius B;
Atherosclerosis; 2009 Sep; 206(1):298-302. PubMed ID: 19303072
[TBL] [Abstract][Full Text] [Related]
19. C-R Relationship between Fasting Plasma Glucose and Unfavorable Outcomes in Patients of Ischemic Stroke withoutDiabetes.
Xing L; Liu S; Tian Y; Yan H; Jing L; Chen K; Yan F; Li Y; Lv J; Sun Y
J Stroke Cerebrovasc Dis; 2019 May; 28(5):1400-1408. PubMed ID: 30871867
[TBL] [Abstract][Full Text] [Related]
20. Sex-specific clinical outcomes of impaired glucose status: A long follow-up from the Tehran Lipid and Glucose Study.
Parizadeh D; Rahimian N; Akbarpour S; Azizi F; Hadaegh F
Eur J Prev Cardiol; 2019 Jul; 26(10):1080-1091. PubMed ID: 30862232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
